HOME >> MEDICINE >> NEWS
New Findings On Dopamine Receptor Biology: Implications For Mental Illness

A team of researchers led by Northeastern University professor Richard C. Deth has discovered a link between dopamine receptors and cognition that could open new avenues for the treatment of conditions like schizophrenia and attention deficit/hyperactivity disorder. The findings are published in the May 1999 edition of Molecular Psychiatry.

The breakthrough centers around the brain's folate pathways and the D-4 dopamine receptor, which is thought to play a vital role in human attention and cognition. Deth's group found that dopamine's interaction with the D-4 receptor can cause local increases in the fluidity of nerve membranes which can influence synapse activity critical for normal cognition and attention.

While researchers have long suspected that dopamine and folate contribute to mental illness, they have not been able to show how. Deth's team has demonstrated that D-4 activity uses the folate pathway as a source of single-carbon methyl groups essential to affecting changes in nerve cell membranes. When this process is defective, it might contribute to schizophrenia or other psychiatric disorders.

Researchers from Northeastern University's Department of Pharmaceutical Sciences, the VA Medical Center in Bedford, MA and the University of Tennessee School of Medicine in Memphis contributed to the study.


'"/>

Contact: Julie Vianello
j.vianello@stockton-press.co.uk
301-496-6885
Molecular Psychiatry
19-May-1999


Page: 1

Related medicine news :

1. Findings support shorter course of radiation therapy after breast lumpectomy
2. Findings of Griffiths review into allegations of research misconduct fundamentally flawed
3. New Findings On Asthma And Breastfeeding, Obesity And Asthma And Snoring And Pre-eclampsia At ALA/ATS Meeting
4. Reassuring Findings About Infants Exposed To Zidovudine
5. Worlds Premier Pharmaceutical Scientists Share Latest R&D Findings
6. Experts To Discuss Findings From New Lewin Group Study In Conference Call Briefing
7. Over 6,000 Technical Presentations Will Reveal New Findings At National Chemists Meeting In Boston, August 23 - 27
8. Dopamine key to learning likes and dislikes, says Colorado U. team
9. Its a gamble: Dopamine levels tied to uncertainty of rewards
10. Dopamine may play role in cue-induced craving distinct from its role regulating reward effects
11. Breakthrough? Study Finds Dopamine Cannot Be Source Of Pleasure In Brain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
Breaking Medicine Technology:
Cached News: